Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
Clinical trial NCT04658147 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04658147
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2025-09-02
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.